SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-024522
Filing Date
2019-05-08
Accepted
2019-05-08 16:31:42
Documents
51
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tv519565_10q.htm 10-Q 350907
2 EXHIBIT 31.1 tv519565_ex31-1.htm EX-31.1 10844
3 EXHIBIT 31.2 tv519565_ex31-2.htm EX-31.2 10814
4 EXHIBIT 32.1 tv519565_ex32-1.htm EX-32.1 4403
5 EXHIBIT 32.2 tv519565_ex32-2.htm EX-32.2 4233
  Complete submission text file 0001144204-19-024522.txt   4312171

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sbot-20190331.xml EX-101.INS 1342291
7 XBRL TAXONOMY EXTENSION SCHEMA sbot-20190331.xsd EX-101.SCH 30639
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbot-20190331_cal.xml EX-101.CAL 30709
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbot-20190331_def.xml EX-101.DEF 181208
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbot-20190331_lab.xml EX-101.LAB 239888
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbot-20190331_pre.xml EX-101.PRE 212848
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 19807086
SIC: 2834 Pharmaceutical Preparations